dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Ruiz-Falcó Rojas, María Luz |
dc.contributor.author | Feucht, Martha |
dc.contributor.author | Macaya Ruíz, Alfons |
dc.contributor.author | Wilken, Bernd |
dc.contributor.author | Hahn, Andreas |
dc.contributor.author | Maamari, Ricardo |
dc.date.accessioned | 2022-09-09T14:48:36Z |
dc.date.available | 2022-09-09T14:48:36Z |
dc.date.issued | 2022-04-08 |
dc.identifier.citation | Ruiz-Falcó Rojas ML, Feucht M, Macaya A, Wilken B, Hahn A, Maamari R, et al. Real-World Evidence Study on the Long-Term Safety of Everolimus in Patients With Tuberous Sclerosis Complex: Final Analysis Results. Front Pharmacol. 2022 Apr 8;13:802334. |
dc.identifier.issn | 1663-9812 |
dc.identifier.uri | https://hdl.handle.net/11351/8131 |
dc.description | Everolimus; Estudi de seguretat posterior a l'autorització; Complex d'esclerosi tuberosa |
dc.description.sponsorship | This study was funded by Novartis Pharmaceuticals Corporation. |
dc.language.iso | eng |
dc.publisher | Frontiers Media |
dc.relation.ispartofseries | Frontiers in Pharmacology;13 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Avaluació de resultats (Assistència sanitària) |
dc.subject | Esclerosi tuberosa - Tractament |
dc.subject.mesh | Tuberous Sclerosis |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Treatment Outcome |
dc.title | Real-World Evidence Study on the Long-Term Safety of Everolimus in Patients With Tuberous Sclerosis Complex: Final Analysis Results |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3389/fphar.2022.802334 |
dc.subject.decs | esclerosis tuberosa |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | resultado del tratamiento |
dc.relation.publishversion | https://doi.org/10.3389/fphar.2022.802334 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Ruiz-Falcó Rojas ML] Hospital Infantil Universitario Nino Jesus, Madrid, Spain. [Feucht M] Universitäts-Klinik für Kinder-und Jugendheilkunde Wien, Vienna, Austria. [Macaya A] Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Wilken B] Klinikum Kassel GmbH, Kassel, Germany. [Hahn A] Abteilung Kinderneurologie, Universitätsklinikum Giessen und Marburg GmbH, Giessen, Germany. [Maamari R] Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States |
dc.identifier.pmid | 35462939 |
dc.identifier.wos | 000790985200001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |